China's gene-editing startup Qihan Biotech raises $25.5m in Series A+ round

China's gene-editing startup Qihan Biotech raises $25.5m in Series A+ round

23 September, 2019

CMBI gene-editing Qihan Biotech Sequoia Capital China

Printed by Unregistered user on Sat, 12 Jul 2025 06:43:35 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Digest: Unisound, Qihan Biotech, Madaket Health, Songxiaocai snag funding

Venture Capital

Advantech, CMBI lead $70m Series C round in China's InventisBio

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims